⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 33 in last 7 days 🍎 Food: 79 in last 7 days 🧸 Products: 98 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 32 minutes ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 33 in last 7 days 🍎 Food: 79 in last 7 days 🧸 Products: 98 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 32 minutes ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT May 27, 2026

Dabigatranetexilat 1A Pharma 110 mg - Hartkapseln 110 mg (Hartkapsel)

📷 Wikipedia: Dabigatran · Source
Dabigatranetexilat 1A Pharma 110 mg - Hartkapseln 110 mg (Hartkapsel)
📷 Wikipedia: Dabigatran · Source
Dabigatranetexilat 1A Pharma 110 mg hard capsules are affected.
⚠️
Shortage ongoing
DABIGATRANETEXILATMESILAT is currently in short supply in AT.
📈 Timeline
13 days active so far
May 29, 2026 June 10, 2026

What is this? Dabigatranetexilat is a medicine in capsules. It helps stop blood clots.

What's happening? Some packs of 110 mg capsules are not available. Only the 60- and 30-capsule boxes can still be bought.

Does this affect me? If you take this medicine, check your pack size. The 10-capsule box is out of stock.

What should I do? Ask your pharmacist or doctor for help if you cannot find your usual pack.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
DABIGATRANETEXILATMESILAT
Agency-published detail

ATC: B01AE07 · Reason: Erhöhter Mehrbedarf · Marketing authorisation holder: 1 A Pharma GmbH, Jakov-Lind-Straße 5/3.05, 1020 Wien, Österreich · Affected packs: 10 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-05-27] · 60 Stück Schachtel, Blisterpackung [verfügbar] · 30 Stück Schachtel, Blisterpackung [verfügbar]

First published
May 27, 2026
Last refreshed by us
6 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

High AT 2 months ago

Dabigatranetexilat 1A Pharma 75 mg - Hartkapseln 75 mg (Hartkapsel)

Dabigatranetexilat 1A Pharma 75 mg hard capsules are affected.
High AT 2 months ago

Dabigatranetexilat 1A Pharma 150 mg - Hartkapseln 150 mg (Hartkapsel)

Dabigatranetexilate 1A Pharma 150 mg hard capsules.
High AT resolved 5 months ago

Dabahib 150 mg-Hartkapseln 150 mg (Hartkapsel)

Shortage of Dabahib 150 mg hard capsules due to manufacturing delays.
High AT resolved 5 months ago

Dabahib 110 mg-Hartkapseln 110 mg (Hartkapsel)

Dabahib 110 mg hard capsules are currently unavailable due to manufacturing delays. The 30-count and 10-count packs have been out of stock since January 2026, with restocking expected in May 2026. The...
High AT resolved 7 months ago

Dabahib 75 mg-Hartkapseln 75 mg (Hartkapsel)

Shortage of Dabahib 75 mg hard capsules due to manufacturing delays. The 30-capsule pack remains available; the 10-capsule pack is temporarily out of stock. Both are expected to be restocked on 26 May...

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Dabigatranetexilat 1A Pharma 110 mg - Hartkapseln 110 mg (Hartkapsel). Dabigatranetexilat 1A Pharma 110 mg hard capsules are affected.
▸ When was this alert issued?
This alert was issued on May 27, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.